Valeritas Holdings

General Information
Business:

(Not an initial public offering. From the prospectus: “Our common stock currently is quoted on the OTCQB Marketplace, operated by OTC Markets Group, under the symbol “VLRXD.” The last reported sale price of our common stock on the OTCQB Marketplace on March 20, 2017, was $10.10 per share. We expect the public offering price to be between $9.00 and $11.00 per share.”

We are a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. We designed our first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, to help patients with Type 2 diabetes who require insulin to achieve and maintain their target blood glucose goals.

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 82
Founded: 2016
Contact Information
Address 750 Route 202 South, Suite 600, Bridgewater, NJ 08807, US
Phone Number (908) 927-9920
Web Address http://www.valeritas.com
View Prospectus: Valeritas Holdings
Financial Information
Market Cap $76.4mil
Revenues $19.6 mil (last 12 months)
Net Income $-46.6 mil (last 12 months)
IPO Profile
Symbol VLRX
Exchange NASDAQ
Shares (millions): 5.3
Price range $10.00 - $10.00
Est. $ Volume $52.5 mil
Manager / Joint Managers Cowen and Company/ Wedbush PacGrow
CO-Managers Roth Capital Partners/ B. Riley & Co.
Expected To Trade: 3/23/2017
Status:
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change